SCHEMBL4276258

SCHEMBL4276258

O=C(O)CCC(=O)CCO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 1/20 0.57
EGLN1 Q9GZT9 4/20 0.56
LMNA P02545 4/20 0.56
ALKBH5 Q6P6C2 1/20 0.56
SUCNR1 Q9BXA5 1/20 0.56
GABRR1 P24046 1/20 0.52
CAMK2A Q9UQM7 1/20 0.50
KDM4E B2RXH2 3/20 0.48
KDM5C P41229 3/20 0.48
PHF8 Q9UPP1 3/20 0.48
KDM2A Q9Y2K7 3/20 0.48
KDM6B O15054 2/20 0.48
GPR84 Q9NQS5 1/20 0.46
FFAR1 O14842 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
CYP2C19 P33261 1/20 0.44
SLC15A2 Q16348 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28180482 1.00 ACE (0.57) ACEEGLN1LMNAALKBH5SUCNR1
SCHEMBL25203 0.87 LMNA (0.75) ACEEGLN1LMNAALKBH5SUCNR1
SCHEMBL1603817 0.87 LMNA (0.75) ACEEGLN1LMNAALKBH5SUCNR1
SCHEMBL22464687 0.87 LMNA (0.75) ACEEGLN1LMNAALKBH5SUCNR1
SCHEMBL30203931 0.87 LMNA (0.75) ACEEGLN1LMNAALKBH5SUCNR1
SCHEMBL4202343 0.87 ACE (0.38) ACEEGLN1LMNAALKBH5SUCNR1
SCHEMBL562396 0.87 LMNA (0.75) ACEEGLN1LMNAALKBH5SUCNR1
SCHEMBL483277 0.83
SCHEMBL27729446 0.82 GPR84 (0.62) ACELMNACAMK2AGPR84FFAR1
SCHEMBL15697547 0.80 GPR84 (0.67) ACEEGLN1LMNAALKBH5SUCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12104160-B2 Production of 4,6-dihydroxy-2-oxo-hexanoic acid ZYMOCHEM, INC. (US) 2024-10-01 US disclosed
CN-117486710-A Photocatalytic synthesis method of succinic acid compounds 北京大学 2024-02-02 CN disclosed
US-20220389433-A1 HIGH YIELD ROUTE FOR THE PRODUCTION OF COMPOUNDS FROM RENEWABLE SOURCES ZYMOCHEM, INC. 2022-12-08 US disclosed
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
US-20200255840-A1 HIGH YIELD ROUTE FOR THE PRODUCTION OF 1, 6-HEXANEDIOL ZYMOCHEM INC (US) 2020-08-13 US disclosed
US-9994881-B2 Functionalized carboxylic acids and alcohols by reverse fatty acid oxidation in engineered microbes WILLIAM MARSH RICE UNIVERSITY (US) 2018-06-12 US disclosed
EP-2753689-B1 FUNCTIONALIZED CARBOXYLIC ACIDS AND ALCOHOLS BY REVERSE FATTY ACID OXIDATION UNIV RICE WILLIAM M (US) 2018-02-14 EP disclosed
US-20170044551-A1 HIGH YIELD ROUTE FOR THE PRODUCTION OF COMPOUNDS FROM RENEWABLE SOURCES ZYMOCHEM INC. 2017-02-16 US disclosed
US-20160237208-A1 Multifunctional Degradable Nanoparticles with Control over Size and Functionalities UNIV VANDERBILT (US) 2016-08-18 US disclosed
EP-3047030-A2 A HIGH YIELD ROUTE FOR THE PRODUCTION OF COMPOUNDS FROM RENEWABLE SOURCES Zymochem Inc. (US) 2016-07-27 EP disclosed
CN-105745327-A High-yield route for producing compounds from renewable resources 兹莫克姆有限公司 2016-07-06 CN disclosed
WO-2015042201-A2 A HIGH YIELD ROUTE FOR THE PRODUCTION OF COMPOUNDS FROM RENEWABLE SOURCES ZYMOCHEM INC. (US) 2015-03-26 WO disclosed
US-20140273110-A1 FUNCTIONALIZED CARBOXYLIC ACIDS AND ALCOHOLS BY REVERSE FATTY ACID OXIDATION WILLIAM MARSH RICE UNIVERSITY (US) 2014-09-18 US disclosed
US-20130142733-A1 MULTIFUNCTIONAL DEGRADABLE NANOPARTICLES WITH CONTROL OVER SIZE AND FUNCTIONALITIES VANDERBILT UNIVERSITY (US) 2013-06-06 US disclosed
US-8173764-B2 Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers ALLEXCEL INC. (US) 2012-05-08 US disclosed
US-20100260743-A1 Solubilization and Targeted Delivery of Drugs With Self-Assembling Amphiphilic Polymers ALLEXCEL, INC. (US) 2010-10-14 US disclosed
US-20100239659-A1 SELF-ASSEMBLING AMPHIPHILIC POLYMERS AS ANTI-CANCER AGENTS ALLEXCEL., INC. (US) 2010-09-23 US disclosed
US-7511160-B2 Lactone derivative and its manufacturing method TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2009-03-31 US disclosed
US-7511160-B2 Lactone derivative and its manufacturing method TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2009-03-31 US disclosed
US-4902512-A Rhamnolipid liposomes DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY AND SHIN-ETSU CHEMICAL CO., LTD. (JP) 1990-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239659-A1 SELF-ASSEMBLING AMPHIPHILIC POLYMERS AS ANTI-CANCER AGENTS CD44, EPCAM, EGFR ACE 4006/4885EGLN1 4706/4885LMNA 2786/4885
US-20130142733-A1 MULTIFUNCTIONAL DEGRADABLE NANOPARTICLES WITH CONTROL OVER SIZE AND FUNCTIONALITIES DSTN, PARN, CTSA ACE 648/4885EGLN1 623/4885LMNA 1043/4885
US-20100260743-A1 Solubilization and Targeted Delivery of Drugs With Self-Assembling Amphiphilic Polymers CD44, ABCG2, ABCC1 ACE 2022/4885EGLN1 4649/4885LMNA 1169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.